These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28963550)

  • 1. Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivo.
    Llavero Hurtado M; Fuller HR; Wong AMS; Eaton SL; Gillingwater TH; Pennetta G; Cooper JD; Wishart TM
    Sci Rep; 2017 Sep; 7(1):12412. PubMed ID: 28963550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
    Luiro K; Kopra O; Lehtovirta M; Jalanko A
    Hum Mol Genet; 2001 Sep; 10(19):2123-31. PubMed ID: 11590129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons.
    Parviainen L; Dihanich S; Anderson GW; Wong AM; Brooks HR; Abeti R; Rezaie P; Lalli G; Pope S; Heales SJ; Mitchison HM; Williams BP; Cooper JD
    Acta Neuropathol Commun; 2017 Oct; 5(1):74. PubMed ID: 29041969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.
    Kielar C; Wishart TM; Palmer A; Dihanich S; Wong AM; Macauley SL; Chan CH; Sands MS; Pearce DA; Cooper JD; Gillingwater TH
    Hum Mol Genet; 2009 Nov; 18(21):4066-80. PubMed ID: 19640925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. in vivo localization of the neuronal ceroid lipofuscinosis proteins, CLN3 and CLN7, at endogenous expression levels.
    Mohammed A; O'Hare MB; Warley A; Tear G; Tuxworth RI
    Neurobiol Dis; 2017 Jul; 103():123-132. PubMed ID: 28365214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Burkovetskaya M; Karpuk N; Kielian T
    Neurobiol Dis; 2017 Apr; 100():19-29. PubMed ID: 28042098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
    J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis.
    Cooper JD; Russell C; Mitchison HM
    Biochim Biophys Acta; 2006 Oct; 1762(10):873-89. PubMed ID: 17023146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular neuropathology of the synapse in sheep with CLN5 Batten disease.
    Amorim IS; Mitchell NL; Palmer DN; Sawiak SJ; Mason R; Wishart TM; Gillingwater TH
    Brain Behav; 2015 Nov; 5(11):e00401. PubMed ID: 26664787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage.
    Dannhausen K; Möhle C; Langmann T
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30042155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach.
    Scifo E; Szwajda A; Dębski J; Uusi-Rauva K; Kesti T; Dadlez M; Gingras AC; Tyynelä J; Baumann MH; Jalanko A; Lalowski M
    J Proteome Res; 2013 May; 12(5):2101-15. PubMed ID: 23464991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.
    Pontikis CC; Cella CV; Parihar N; Lim MJ; Chakrabarti S; Mitchison HM; Mobley WC; Rezaie P; Pearce DA; Cooper JD
    Brain Res; 2004 Oct; 1023(2):231-42. PubMed ID: 15374749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers.
    Sleat DE; Tannous A; Sohar I; Wiseman JA; Zheng H; Qian M; Zhao C; Xin W; Barone R; Sims KB; Moore DF; Lobel P
    J Proteome Res; 2017 Oct; 16(10):3787-3804. PubMed ID: 28792770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.
    Kühl TG; Dihanich S; Wong AM; Cooper JD
    J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the juvenile Batten disease gene, CLN3, and the Notch and JNK signalling pathways.
    Tuxworth RI; Vivancos V; O'Hare MB; Tear G
    Hum Mol Genet; 2009 Feb; 18(4):667-78. PubMed ID: 19028667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.
    Xiong J; Kielian T
    J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender.
    Kovács AD; Pearce DA
    Dis Model Mech; 2015 Apr; 8(4):351-61. PubMed ID: 26035843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.
    Hersrud SL; Kovács AD; Pearce DA
    Biochim Biophys Acta; 2016 Jul; 1862(7):1324-36. PubMed ID: 27101989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.